Hyperlipidemia: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 13: | Line 13: | ||
==[[Hyperlipidemia overview | Overview]]== | ==[[Hyperlipidemia overview | Overview]]== | ||
==[[Hyperlipidemia risk factors | Risk factors]]== | ==[[Hyperlipidemia risk factors | Risk factors]]== | ||
==[[Hyperlipidemia causes | Causes]]== | |||
==[[Hyperlipidemia screening | Screening]]== | ==[[Hyperlipidemia screening | Screening]]== | ||
[[Hyperlipidemia primary prevention | Target population]] | [[Hyperlipidemia screening tests | Screening tests]] | [[Hyperlipidemia screening frequency | Screening frequency]] | |||
[[Hyperlipidemia | ==[[Hyperlipidemia classification | Classification]]== | ||
==Treatment== | ==Treatment== | ||
Revision as of 17:30, 30 October 2011
For patient information click here Template:DiseaseDisorder infobox
|
Lipoprotein Disorders Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Risk factors
Causes
Screening
Target population | Screening tests | Screening frequency
Classification
Treatment
NCEP recommendations for children and adolescents with high-risk hyperlipidemia
Recommendations for drug therapy | Statins | Adjuvant therapies
References
External links
| Hyperlipoproteinemia | OMIM | GPnotebook | WebMD | Others |
|---|---|---|---|---|
| Type I | Online Mendelian Inheritance in Man (OMIM) 238600 | Template:GPnotebook | . | MeritCare |
| Type IIa | Online Mendelian Inheritance in Man (OMIM) 144400 | Template:GPnotebook | . | Merck |
| Type IIb | Template:GPnotebook | . | ||
| Type III | . | Template:GPnotebook | WebMD | Yahoo |
| Type IV | Online Mendelian Inheritance in Man (OMIM) 144600 | Template:GPnotebook | WebMD | Yahoo |
| Type V | Online Mendelian Inheritance in Man (OMIM) 144600 | Template:GPnotebook | . | . |